A Cell-Free Product Secreted by Ly2+ Cells can Induce a Molecule Required for Ly2 Suppressor Cell Activity

  • Patrick M. Flood
  • Diane Louie
  • Richard K. Gershon


The generation of suppression to SRBC in vitro involves the interaction of different T cell subsets in a well defined regulatory “feedback” circuit. The cells of this circuit have been identified by the correlation of function with a unique profile of cell surface glycoproteins (differentiation antigens). The induction signal is delivered by an I-J+ Ly1+2 cell to an Ly1+2+ I-J+ acceptor cell (1,2). The interaction between the Ly1 inducer cell and the Ly1,2 transducer cell is antigen-specific and restricted by genes linked to the V-region of the immunoglobulin heavy chain locus. The transducer cell then activates the effector cell of the suppressor circuit. One mechanism by which this takes place is the differentiation of transducer cells into effector cells (3). Other mechanisms may exist. The effector cell is so called because of its ability to suppress Ly1 cells directly, without the need for an Ly1,2 transducer cell (4). These effector cells are capable of suppressing not only helper cells, but also the feedback inducer cells. This results not only in a shutdown of antibody synthesis but abrogates additional T suppressor induction and thereby completing the feedback circuit. The phenotype of the effector cell is an Ly12+ and, unlike the other cells of the feedback circuit, it does not bear the I-J subregion gene products (4). This is especially important in light of the fact that the interaction between the suppressor effector cell and its target is partially restricted by genes mapping into this same I-J subregion of the MHC.


Antigen Binding Assay Culture Plaque Form Cell Transducer Cell Binding Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cantor, H. and Gershon, R.K., Fed. Proc. 38: 2058 (1979).PubMedGoogle Scholar
  2. 2.
    Yamauchi, K., Murphy, D.B., Cantor, H. and Gershon, R.K., Eur. J. Immunol. 11: 905 (1981).PubMedCrossRefGoogle Scholar
  3. 3.
    McDougal, J.S., Shen, F.W., Cort, S.P. and Bard, J., J. Immunol. 125: 1157 (1980).PubMedGoogle Scholar
  4. 4.
    Yamauchi, K., Murphy, D.B., Cantor, H. and Gershon, R.K., Eur. J. Immunol. 11: 913 (1981).PubMedCrossRefGoogle Scholar
  5. 5.
    Yamauchi, K., Chao, N., Murphy, D.B. and Gershon, R.K., J. Exp. Med. 155: 655 (1981).CrossRefGoogle Scholar
  6. 6.
    Chao, N., Thesis, Yale University School of Medicine, New Haven, Connecticut (1981).Google Scholar
  7. 7.
    Flood, P.M., Yamauchi, K. and Gershon, R.K., J. Exp. Med. 156: 361 (1982).PubMedCrossRefGoogle Scholar
  8. 8.
    Flood, P.M. and Gershon, R.K., manuscript in preparation.Google Scholar
  9. 9.
    Wysocki, L.J. and Sato, V.L. Proc. Natl. Acad. Sci. U.S.A. 75: 2844 (1978).PubMedCrossRefGoogle Scholar
  10. 10.
    Cunningham, A.J. and Szenberg, A., Immunology 14: 599 (1968).PubMedGoogle Scholar
  11. 11.
    Catt, K.J. and Dufau, M.L., in: “Endocrinology and Metabolism”, P.H. Felig, J.D. Baxter, A.H. Broadus, and L.A. Frohman, Eds., pp. 61–105 (1981).Google Scholar
  12. 12.
    Fresno, M., McVay-Boudreau, L., Furthmayr, H. and Cantor, H., J. Exp. Med. 153: 1246 (1981).PubMedCrossRefGoogle Scholar
  13. 13.
    Fresno, M., McVay-Boudreau, L., Nobel, G. and Cantor, H., J. Exz. Med. 153: 1260 (1981).CrossRefGoogle Scholar
  14. 14.
    Ptak, W., Rosenstein, R.W. and Gershon, R.K., Proc. Natl. Acad. Sci. U.S.A. 79: 2375 (1981).CrossRefGoogle Scholar
  15. 15.
    Taniguchi, M., Saito, T., Tahei, I. and Tokuhisa, T., J. Exp. Med. 153: 1672 (1981).PubMedCrossRefGoogle Scholar
  16. 16.
    Taussig, M.J. and Holliman, A., Nature (Lond.) 277: 308 (1979).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Patrick M. Flood
    • 1
  • Diane Louie
    • 1
  • Richard K. Gershon
    • 1
  1. 1.Department of Pathology, The Howard Hughes Institute for Cellular ImmunologyYale University School of MedicineNew HavenUSA

Personalised recommendations